Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Equinix

NEW YORK, May 6, 2024 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Equinix, Inc. (“Equinix” or the “Company”) (NASDAQ: EQIX) and reminds investors of the July 1, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been … Read more

Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Choice Hotels International, Inc. (NYSE: CHH)

NEW YORK, April 26, 2024 /PRNewswire/ — Levi & Korsinsky announces that it has commenced an investigation of Choice Hotels International, Inc. (NYSE: CHH) concerning possible breaches of fiduciary duty. To obtain additional information, go to: https://zlk.com/compensation2/choice-hotels-international-inc-lawsuit-submission-form    or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500. There … Read more

GoodRx Holdings, Inc. (GDRX) Investors: June 21, 2024 Filing Deadline in Securities Class Action

RADNOR, Pa., April 26, 2024 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against GoodRx Holdings, Inc. (NASDAQ: GDRX) (“GoodRx” or the “Company”) on behalf of investors who purchased or acquired GoodRx common stock between September 23, 2020, … Read more

Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global Cord

NEW YORK, April 23, 2024 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Global Cord Blood Corporation (“Global Cord” or the “Company”) (NYSE: CO) (OTC: CORBF) and reminds investors of the June 24, 2024 deadline to seek the role of lead plaintiff in a federal securities … Read more

Global Corneal Implant Market is Expected to Showcase a Significant Growth at a CAGR of ~6% by 2030

The surge in demand for corneal implants stems mainly from the rise in instances of corneal blindness, eye injuries, and conditions like ocular hypertension (glaucoma). Moreover, the growing collaboration among industry stakeholders to innovate in corneal implant technology, alongside the limited availability of cornea donors, is anticipated to drive the expansion of the corneal implant … Read more

Lead Plaintiff Deadline on May 20, 2024 for The Chemours Company Investors

RADNOR, Pa., April 21, 2024 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) (“Chemours” or the “Company”) on behalf of investors who purchased or acquired Chemours common stock between February 10, 2023 … Read more

Kessler Topaz Meltzer & Check, LLP Reminds Investors of Doximity, Inc. (DOCS) that a Securities Fraud Class Action Lawsuit Has Been Filed On Their Behalf

RADNOR, Pa., April 20, 2024 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against Doximity, Inc. (NYSE: DOCS) (“Doximity” or the “Company”) on behalf of investors who purchased or acquired Doximity common stock between February 9, 2022, and … Read more

Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of VinFast Auto

NEW YORK, April 16, 2024 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against VinFast Auto Ltd. (“VinFast” or the “Company”) (NASDAQ: VFS) f/k/a Black Spade Acquisition Co. (“Black Spade”) and reminds investors of the June 11, 2024 deadline to seek the role of lead plaintiff in … Read more

Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantronix

NEW YORK, April 13, 2024 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lantronix, Inc. (“Lantronix” or the “Company”) (NASDAQ: LTRX) and reminds investors of the April 23, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been … Read more

Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ventyx Biosciences

NEW YORK, April 13, 2024 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX) and reminds investors of the April 30, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has … Read more